Category

China

China: Xiamen International Port H, China Power International, Modern Land China, iRay Technology and more

By | China, Daily Briefs

In today’s briefing:

  • Merger Arb Mondays (6 Jun) – Xiamen Port, Link Admin, Cocoaland, Link Net, Australian Unity Office
  • China Power International (2380 HK): Moving in the Right Direction
  • Morning Views Asia: Modern Land China
  • IRay Technology (688301.CH) – Limited Market Space Casts Doubt on Future Growth Potential


China Power International (2380 HK): Moving in the Right Direction

By Osbert Tang, CFA

  • We think the underperformance of China Power International (2380 HK) (CPI) against the market in this year is unjustified given a projected improvement in profitability.
  • CPI has secured coal supply with more than 60% of contracts on annual long-term basis within the benchmark price range. Also, power tariff is expected to be on an uptrend.
  • The proposed new management incentive scheme will better align management’s and shareholders’ interests. CPI also indicated good room to lower leverage in this year while sustaining growth. 

Morning Views Asia: Modern Land China

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


IRay Technology (688301.CH) – Limited Market Space Casts Doubt on Future Growth Potential

By Xinyao (Criss) Wang

  • IRay’s performance has shown a trend of accelerating growth in 2021/2022Q1, mainly driven by the mobile DR sales during COVID-19 as well as the dental (CBCT) and industrial security businesses.
  • The sales of mobile DR would slow down after COVID is under control. The decreasing price due to fierce competition in grassroots markets would finally drag down gross profit margin. 
  • The concern is that the market space (DR/dental/industrial fields) is not big, with obvious growth ceiling. So, we lowered our revenue/profit margin forecast and we think iRay is overvalued 

Before it’s here, it’s on Smartkarma

China: New World Development, Tsingtao Brewery Co Ltd H, Alibaba Group, CK Hutchison Holdings Ltd and more

By | China, Daily Briefs

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: NKY, CSI300, SSE, REMX, ASX, SET50, CH50/A50, EPRA, Mercari, GOTO
  • ECM Weekly (5th June 2022) – Tsingtao, Woodside, Digital Tel, CALB, Scivita
  • Longleaf Partners Asia Pacific UCITS Fund Q1 2022 Commentary
  • Longleaf Partners Global UCITS Fund Q1 2022 Commentary

Index Rebalance & ETF Flow Recap: NKY, CSI300, SSE, REMX, ASX, SET50, CH50/A50, EPRA, Mercari, GOTO

By Brian Freitas


ECM Weekly (5th June 2022) – Tsingtao, Woodside, Digital Tel, CALB, Scivita

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • IPO volumes remain subdued across the region, although a number of deals are said to be looking to launch soon.
  • Placements stole the limelight this week with Tsingtao, Woodside and Digital Tel Infra all managing to do well.

Longleaf Partners Asia Pacific UCITS Fund Q1 2022 Commentary

By Fund Newsletters

  • Longleaf Partners Funds is a suite of mutual funds and UCITS funds that Southeastern Asset Management, the investment advisor to the Longleaf Partners Funds, created in 1987 as a way for Southeastern employees to invest alongside their clients.
  • Longleaf Partners Asia Pacific UCITS Fund returned -7.48% in the first quarter, trailing the MSCI AC Asia Pacific Index.
  • There is an immense opportunity to be in the right companies as they close that massive discount to a more reasonable discount versus global peers.

Longleaf Partners Global UCITS Fund Q1 2022 Commentary

By Fund Newsletters

  • Longleaf Partners Funds is a suite of mutual funds and UCITS funds that Southeastern Asset Management, the investment advisor to the Longleaf Partners Funds, created in 1987 as a way for Southeastern employees to invest alongside their clients.
  • Longleaf Partners Global UCITS Fund declined 5.02% in the first quarter, roughly in line with the MSCI World’s 5.15% decline.
  • The Fund saw a continuation of China/Hong Kong exposure weighing on absolute and relative returns.
  • We are close to fully invested with approximately 8% cash, and our on-decklist is growing longer amid market volatility.
  • We believe our companies in Asia and Europe are well positioned to navigatethe challenges facing each region today.

Before it’s here, it’s on Smartkarma

China: Xiamen International Port H, Shanghai Putailai New Energy Technology, Tsingtao Brewery Co Ltd H, Country Garden Holdings Co, Agile Property Holdings, Alibaba Group, Weibo Corp, CNX Resources and more

By | China, Daily Briefs

In today’s briefing:

  • Xiamen Port (3378 HK)’s Pre-Conditional Offer
  • Shanghai/​​Shenzhen Northbound Connect: Weekly Moves (2 June 2022)
  • Shanghai/​​Shenzhen Southbound Connect: Weekly Moves (2 June 2022)
  • Weekly Wrap – 03 Jun 2022
  • Weekly Wrap – 03 Jun 2022
  • Chinese Property Weekly – 3 June 2022 – Lucror Analytics
  • Chinese Property Weekly – 3 June 2022 – Lucror Analytics
  • Longleaf Partners International Fund Q1 2022 Commentary
  • Weibo (WB US): Ad Growth Clouded by Pandemic and Macro Slowdown
  • Longleaf Partners Global Fund Q1 2022 Commentary

Xiamen Port (3378 HK)’s Pre-Conditional Offer

By David Blennerhassett

  • SOE terminal operator Xiamen International Port (3378 HK) has announced a pre-conditional Offer from Xiamen Port Holding, a Fujian SASAC-controlled entity.
  • The Offer price is HK$2.25 per H-share, a 55% premium to last close. The Offer price will NOT be increased. The final dividend will be added to the cancellation price. 
  • Pre-Conditions include approvals from NDRC, MoC, SAFE, and CSRC. There is no tendering condition. This deal mirrors Guodian Technology (1296 HK), BCL (2868 HK), and Jin Jiang Capital (2006 HK).

Shanghai/​​Shenzhen Northbound Connect: Weekly Moves (2 June 2022)

By David Blennerhassett


Shanghai/​​Shenzhen Southbound Connect: Weekly Moves (2 June 2022)

By David Blennerhassett


Weekly Wrap – 03 Jun 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Evergrande
  2. Logan Property Holdings
  3. Times China
  4. Ronshine China Holdings
  5. China Jinmao Holdings

and more…


Weekly Wrap – 03 Jun 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Evergrande
  2. Logan Property Holdings
  3. Times China
  4. Ronshine China Holdings
  5. China Jinmao Holdings

and more…


Chinese Property Weekly – 3 June 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Chinese Property Weekly – 3 June 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Longleaf Partners International Fund Q1 2022 Commentary

By Fund Newsletters

  • Longleaf Partners Funds is a suite of mutual funds and UCITS funds that Southeastern Asset Management, the investment advisor to the Longleaf Partners Funds, created in 1987 as a way for Southeastern employees to invest alongside their clients.
  • Longleaf Partners International Fund declined 12.04% in the first quarter, while the MSCI EAFE Index declined 5.91%.
  • New investments have a high hurdle to qualify given our conviction in our current holdings and the steep discount of the portfolio.
  • We believe our companies in Asia and Europe are well positioned to navigatethe challenges facing each region today.

Weibo (WB US): Ad Growth Clouded by Pandemic and Macro Slowdown

By Roger Xie

  • Weibo Corp (WB US) delivered robust 1Q22 results with ad revenue growing 10% year-over-year and outperforming other Chinese social networks, which underscores Weibo’s prominent position for advertisers.
  • However, widespread lockdowns in China and economic slowdown could pressure Weibo in 2Q, and we expect a gradual recovery in 3Q-4Q with limited visibility. 
  • We like Weibo attractive valuation at 10x forward P/E; it has amassed MAU 582 million till March 2022 and user engagement has been improving.

Longleaf Partners Global Fund Q1 2022 Commentary

By Fund Newsletters

  • Longleaf Partners Funds is a suite of mutual funds and UCITS funds that Southeastern Asset Management, the investment advisor to the Longleaf Partners Funds, created in 1987 as a way for Southeastern employees to invest alongside their clients.
  • Longleaf Partners Global Fund declined 5.84% in the first quarter, roughly in line with the MSCI World’s 5.15% decline.
  • In a volatile quarter for markets across the globe, we saw one of the largest disconnects between price and value per share performance that we have seen for our portfolio in a long time.
  • We remain fully invested with less than 2% cash, and our on-deck list isgrowing longer amid market volatility.
  • We believe our companies in Asia and Europe are well positioned to navigatethe challenges facing each region today.

Before it’s here, it’s on Smartkarma

China: Xiamen International Port H, China Shenshan Orchard, Meituan, Country Garden Holdings Co, Burning Rock Biotech, Air China Ltd (H) and more

By | China, Daily Briefs

In today’s briefing:

  • Xiamen Port’s Juicy HK$2.25 Per H Share Privatisation Offer
  • Smartkarma Corporate Webinar | China Shenshan Orchard: Looking Into the Kiwi Kingdom
  • Meituan (3690 HK): 1Q22 Looks Normal, But Layoff Will Slow Down Revenue
  • Hang Seng Index Constituents 2nd June 2022
  • Burning Rock Biotech (BNR US) 1Q22: Double-Digit Revenue Growth; China Re-Opening to Boost Recovery
  • Morning Views Asia: Evergrande, Country Garden Holdings Co, Jingrui Holdings, Meituan
  • Air China to Take Over Embattled Regional Airline
  • Meituan – Omicron Impact Was Not as Big in 1Q but 2Q Will Have the Full Impact

Xiamen Port’s Juicy HK$2.25 Per H Share Privatisation Offer

By Arun George

  • Xiamen International Port H (3378 HK) announced a pre-conditional privatisation offer from Xiamen Port Holding at HK$2.25 per H share + final dividend of RMB0.021 per share (ex-div: 15 June). 
  • The key conditions are approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders’ rejection). There is no minimum acceptance condition.  
  • The offer is attractive in comparison to historical share prices and multiples. We think that the privatisation proposal will likely succeed. At the last close, the gross spread is 55.2%.

Smartkarma Corporate Webinar | China Shenshan Orchard: Looking Into the Kiwi Kingdom

By Smartkarma Research

For our next Corporate Webinar, we are glad to welcome China Shenshan Orchard (DKNG SP) Executive Director, David Zhao.

In the upcoming webinar, David will share a short company presentation, after which he will engage in a fireside chat with Smartkarma Analyst Angus Mackintosh. A live Q&A session will follow.

The Corporate Webinar will be hosted on Tuesday, 28 June 2022, 17:00 SGT.

China Shenshan Orchard Holdings Co. Ltd. is a horticultural company in the business of planting, cultivating, and selling kiwi fruit in the People’s Republic of China (“PRC”). The Group holds forest use rights for eight strategically located orchards, spanning a total land area of 9,805 mu (approximately 6.5 million sqm), which is believed to be one of the largest domestic kiwi fruit orchards concentrated in Chibi City, Hubei, the PRC.

Corporate Webinars by Smartkarma Corporate Solutions feature discussions with IROs and Executives, discussing their companies, the challenges they face, and the opportunities in their sectors and markets.


Meituan (3690 HK): 1Q22 Looks Normal, But Layoff Will Slow Down Revenue

By Ming Lu

  • Revenue growth mainly came from initiatives, which is the focus of April layoff.
  • We believe revenue will slow down and the operating loss will shrink.
  • We set a downside of 11.5% and a price target of HK$160.

Hang Seng Index Constituents 2nd June 2022

By Untying The Gordian Knot

  • The government has taken several steps to improve supply-side restrictions on first and second homes.
  • PBOC has added policy support by cutting longer-dated LPR rates for home loan pricing. Longfor Group and Country Garden are highly rated, large China Real Estate developers.
  • They do not seem to respond positively to many tailwinds

Burning Rock Biotech (BNR US) 1Q22: Double-Digit Revenue Growth; China Re-Opening to Boost Recovery

By Tina Banerjee

  • Burning Rock Biotech (BNR US) reported strong Q1 2022 results, with accelerated double-digit revenue growth of 27% y/y, higher than full year 2022 revenue growth guidance of 22%.
  • Operating loss widened due to 41% y/y surge in opex, primarily attributed to higher staff cost, which resulted from an increase in headcount.
  • Management reiterated 2022 revenue growth guidance of 22% y/y. With Shanghai re-opening, this seems to be achievable.

Morning Views Asia: Evergrande, Country Garden Holdings Co, Jingrui Holdings, Meituan

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Air China to Take Over Embattled Regional Airline

By Caixin Global

  • National flag carrier Air China Ltd. (601111.SH) is planning to take control of Shandong Airlines as part of a bailout of the debt-ridden regional airline, it said this week.
  • The state-owned giant is stepping in as its smaller peer suffers along with the rest of the country’s civil aviation industry, with companies racking up huge losses due to the Covid-19 pandemic.
  • Air China is already the second-largest shareholder of Shandong Airlines Group Co. Ltd. with a 49.4% stake

Meituan – Omicron Impact Was Not as Big in 1Q but 2Q Will Have the Full Impact

By Shifara Samsudeen, ACMA, CGMA

  • Meituan reported 1Q2022 results yesterday. Revenue grew 25.0% YoY to RMB46.3bn (vs consensus RMB45.3bn) while operating losses for the quarter slightly dropped to 12.1% of revenues from 12.9% in 1Q2021.
  • As a result of Omicron spread in March, revenue declined sequentially as all three segments reported QoQ decline in revenue during 1Q2022.
  • Meituan hasn’t reported GTV for food delivery as well as no. of domestic hotel room nights for In-Store, Hotel & Travel which seems strange, suggesting 2Q numbers could be worse.

Before it’s here, it’s on Smartkarma

China: Henderson Land Development, Tongwei Co Ltd A, China Longyuan Power, Calb, WM Motor Technology Co Ltd, ABM Investama, OrbusNeich Medical Group, Bharat Petroleum Corp and more

By | China, Daily Briefs

In today’s briefing:

  • FTSE EPRA Nareit Index Rebalance: Two Adds & Three Deletes with Large Impact
  • FTSE China A50 Index Rebalance: Three Changes, As We Expected
  • FTSE China 50 Index Rebalance: Two Sets of Changes as Expected
  • CALB Pre-IPO – The Negatives – Lots of Shareholder Re-Shuffling
  • WM Motor IPO Initiation: Electric Jitters
  • Asia HY Monthly – Indonesian Bankruptcy Regime Revisited – Lucror Analytics
  • Pre-IPO OrbusNeich Medical Group – The Industry, the Business and the Concerns
  • Morning Views Asia: Bharat Petroleum Corp, Central China Securities, Tata Motors ADR

FTSE EPRA Nareit Index Rebalance: Two Adds & Three Deletes with Large Impact

By Brian Freitas


FTSE China A50 Index Rebalance: Three Changes, As We Expected

By Brian Freitas


FTSE China 50 Index Rebalance: Two Sets of Changes as Expected

By Brian Freitas


CALB Pre-IPO – The Negatives – Lots of Shareholder Re-Shuffling

By Sumeet Singh

  • CALB aims to raise around US$1.5bn in its Hong Kong IPO.
  • CALB undertakes design, R&D, production and sales of EV batteries and Energy Storage Systems (ESS) products. 
  • In this note, we will talk about the not so positive aspects of the deal.

WM Motor IPO Initiation: Electric Jitters

By Arun George

  • WM Motor Technology Co Ltd (WMT CH), an EV manufacturer, has filed for a US$1 billion IPO on the HKEx. It recently raised US$595.7 million at a US$7 billion valuation.
  • In line with industry trends and listed Chinese peers, WM Motor rapidly grew its vehicle deliveries in 2021. Price increases and a good roadmap support future growth. 
  • WM Motor is sub-scale vs peers pointing to an uncertain path to profitability. As the era of being rewarded for growth at any cost is over, the timing feels off.

Asia HY Monthly – Indonesian Bankruptcy Regime Revisited – Lucror Analytics

By Charles Macgregor

This month, we provide an update on developments related to the Indonesian bankruptcy regime since November 2017.

The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks, and discussing specific areas of interest in the “In-Focus” section. The Asia Monthly is intended to broaden investors’ understanding of the Asian USD high-yield market.


Pre-IPO OrbusNeich Medical Group – The Industry, the Business and the Concerns

By Xinyao (Criss) Wang

  • OrbusNeich Medical Group (NEICHZ HK) has a rich pipeline with a leadership position in the PCI balloon markets.
  • Its global business layout would also help the Company “hedge” the negative domestic policy impact or regulation changes.
  • However, the fierce competition, market pattern, industry characteristics, centralized procurement and other concerns should not be neglected.

Morning Views Asia: Bharat Petroleum Corp, Central China Securities, Tata Motors ADR

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: HKBN Ltd, Dongfeng Automobile, Xinyi Glass Holdings, Tencent, iQIYI Inc, AKM Industrial, Scivita Medical Technology, Intco Medical Technology Co., Ltd-A and more

By | China, Daily Briefs

In today’s briefing:

  • (Mostly) Asia M&A: May 2022 Roundup
  • Dongfeng Auto (600006 CH): Dongfeng Motors’ Partial Offer
  • Xinyi Glass Vs Flat Glass: Collapse and Long XYG
  • Tencent: Is Tencent Trying to Cope with Revenue Slowdown?
  • IQiyi – Generates Profits for the First Time; Can It Maintain Its Profitability?
  • AKM’s Scheme Document, Court Meeting on 22 June, IFA Opinion
  • Scivita (新光维医疗) Pre-IPO: Intense Competition Ahead
  • Intco Medical Technology (300677.CH) – Declining Performance & Overcapacity Indicate Gloomy Outlook

(Mostly) Asia M&A: May 2022 Roundup

By David Blennerhassett

  • For the month of May, 10 new deals (firm and non-binding) were discussed on Smartkarma with an overall announced deal size of ~US$26bn.
  • The average premium for the new deals announced (or first discussed) in May was ~53%.
  • This compares to the average premium for all deals in 2021 (165 deals), 2020 (158 deals), and 2019 (145 deals) of 33%, 31%, and 31.5% respectively.

Dongfeng Auto (600006 CH): Dongfeng Motors’ Partial Offer

By David Blennerhassett

  • Dongfeng Motor (489 HK) (DFMG) has entered into an agreement to buy back the controlling stake in Dongfeng Automobile (600006 CH) (DFAC) from Nissan Motor (7201 JP).
  • DFMG and Nissan’s JV (split 50:50) holds a 60.1% stake in DFAC. Under the agreement, 29.9% of the JV’s stake in DFAC will be transferred to DFMG.
  • Subsequent to the completion of the transfer, DFMG will launch a partial offer for 25.1% of DFAC, with a view to holding 55% of shares out in DFAC. 

Xinyi Glass Vs Flat Glass: Collapse and Long XYG

By Henry Soediarko


Tencent: Is Tencent Trying to Cope with Revenue Slowdown?

By Shifara Samsudeen, ACMA, CGMA

  • Tencent reported lowest YoY increase in revenue in 1Q2022. Subsequent to this, Tencent mentioned during earnings call that it continues to scale back on loss-making activities across its business segments.
  • Recent scale back of operation is in its cloud-services segment that includes loss-making activities such as projects with high proportion of sub-contractors and deeply discounted-contracts for CVM and CDN capacity.
  • Layoffs have become prevalent as a cost cutting measure and Tencent is in the process of reducing headcount at gaming and fintech businesses.  

IQiyi – Generates Profits for the First Time; Can It Maintain Its Profitability?

By Shifara Samsudeen, ACMA, CGMA

  • IQiyi reported 1Q2022 results last week. Revenue fell 8.7% YoY to RMB 7.3bn (vs consensus RMB 7.22bn) and reported an OP of RMB 93.4m (vs consensus loss of RMB 297m).
  • Growth in ARM helped offset decline in the number of subscribers for membership revenue. However, online advertising and content distribution both declined due to lack of content and macroeconomic weaknesses.  
  • IQiyi’s shares have gained 11.2% since its earnings announcement as the company reported an OPM for the first time.

AKM’s Scheme Document, Court Meeting on 22 June, IFA Opinion

By Arun George

  • The AKM Industrial (1639 HK) scheme document is out with the court and EGM meeting on 22 June. The IFA considers the offer to be fair and reasonable. 
  • The key condition is the scheme approval by at least 75% and rejection by <10% of disinterested shareholders. Shareholders who hold blocking stakes have provided irrevocables.
  • At last close and for a 4 August payment, the gross and annualised spread to the offer is 1.1% and 6.2%, respectively. This is a done deal.

Scivita (新光维医疗) Pre-IPO: Intense Competition Ahead

By Ke Yan, CFA, FRM

  • Scivita is a China-based medical device company with a focus on single-use endoscope. The company is looking to raise up to USD100 m via a Hong Kong listing.
  • In this note, we look at the company’s background, the industry dynamics and the company’s products.
  • We think the company has a decent investor backing and management team but the intense competition is the main issue.

Intco Medical Technology (300677.CH) – Declining Performance & Overcapacity Indicate Gloomy Outlook

By Xinyao (Criss) Wang

  • Due to the reduction of glove selling price, lower demand, significant cost hike and inflation, it is expected that Intco would continue to face declining performance and margins. 
  • Under current circumstances, supply exceeds demand. The overcapacity could lead to substantial asset impairment. So, it would take some time before the industry clearing is finished or reach new balance.
  • Intco’s weak performance would continue. Its share price is likely to remain depressed for some time.So, it may not be wise to bottom fishing that early even with low valuation.

Before it’s here, it’s on Smartkarma

China: Orient Overseas International, Tsingtao Brewery Co Ltd H, Seazen (Formerly Future Land), Alibaba Group, Pinduoduo, Bilibili, Genscript Biotech, AKM Industrial, Calb, Fantasia Holdings Group Co and more

By | China, Daily Briefs

In today’s briefing:

  • MSCI May 2022 Index Rebalance: Flows at the Close Today & Performance So Far
  • Tsingtao Placement – Ending the Selldowns with the Biggest One so Far
  • CCASS: Why Large Moves Continue To Matter
  • Alibaba: 4QFY22 Beats Consensus but Disappointments Could Be Around the Corner
  • Pinduoduo (PDD): 1Q22, Good Quarter, But Lockdown Scares Third-Party Retailers
  • Bilibili (9626 HK) Pre-Earnings: Layoff Will Slow Down Minor Biz, But More Importantly Cut Loss
  • Genscript Biotech – Commercialized CAR-T & Strong CGT CDMO Indicate Exponential Growth in Valuation
  • AKM (1639 HK): 22nd June Scheme Meeting. IFA Says Fair
  • CALB Pre-IPO – The Positives – Has Been Growing Fast
  • Morning Views Asia: Alam Sutera Realty, Country Garden Holdings Co, Fantasia Holdings Group Co

MSCI May 2022 Index Rebalance: Flows at the Close Today & Performance So Far

By Brian Freitas

  • For Asia Pacific, there are 48 adds/76 deletes for the Standard Indices and 166 adds/147 deletes for the Small Cap Index that will be implemented at the close today.
  • The adds have outperformed the deletes on average over the last few weeks/months. A long adds/short deletes trade performed better for Small Caps as compared to the Standard index.
  • There are a lot of stocks that will have same-way flow from other index trackers over the next few weeks and there could be a higher impact on these names.

Tsingtao Placement – Ending the Selldowns with the Biggest One so Far

By Sumeet Singh

  • Fosun aims to raise around US$527m via selling a 3.5% stake in Tsingtao.
  • This is not the first selldown by Fosun, we have covered three prior deals in Dec 2020, Apr 2021 and Dec 2021.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

CCASS: Why Large Moves Continue To Matter

By David Blennerhassett

  • In this latest installment in a series dating back to March 2018, I’ve analysed 5,500 moves over three years inside CCASS, targeting >5% of shares outstanding of individual stocks. 
  • The data continues to bear out the overall underperformance of stocks that exhibit such moves.
  • Additionally, the movement of large blocks of shares may illustrate that the beneficial owner of those shares has pledged them as collateral for a loan.

Alibaba: 4QFY22 Beats Consensus but Disappointments Could Be Around the Corner

By Oshadhi Kumarasiri

  • Alibaba Group (9988 HK)’s 4QFY22 results were yet another disappointment with the company’s revenue growing by 8.9% YoY, a new low after slowing to 9.7% YoY in the previous quarter.
  • This was mostly priced-in, considering that 4QFY22 revenue and OP exceeded consensus by 2.3% and 216% respectively.
  • However, FY23 and FY24 estimates are still ambitious and there’s a lot of downside risk to consensus from 2QFY22 onwards.

Pinduoduo (PDD): 1Q22, Good Quarter, But Lockdown Scares Third-Party Retailers

By Ming Lu

  • PDD achieved high growth rates in main businesses and a higher operating margin in 1Q22.
  • However, we believe third-party retailers are scared about the logistics problem caused by the lockdown.
  • We set a downside of 17% and a price target of US$40.

Bilibili (9626 HK) Pre-Earnings: Layoff Will Slow Down Minor Biz, But More Importantly Cut Loss

By Ming Lu

  • BILI dismissed employees in game, e-commerce, and video in May.
  • We believe the growth rates of minor businesses will slow down significantly in 1Q22.
  • However, the operating margin will improve in 2022 and 2023.

Genscript Biotech – Commercialized CAR-T & Strong CGT CDMO Indicate Exponential Growth in Valuation

By Xinyao (Criss) Wang

  • The CARVYKTI commercialization will bring GenScript increasing revenue and cash flow. Together with the rapid growth of GCT CDMO, it is expected to see gradual improvement in GenScript’s financial performance.
  • The complex international relations, geopolitical conflicts and anti-globalization risks could weigh on bullish sentiment in the short term or cause stock prices to fluctuate wildly.
  • In the long term, GenScript’s “all-in” on GCT area enables it follow the industry trend closely. So,GenScript have the exponential growth potential in valuation, with possibility of surpassing WuXi Biologics.

AKM (1639 HK): 22nd June Scheme Meeting. IFA Says Fair

By David Blennerhassett

  • The Scheme Document Document for AKM Industrial (1639 HK), a flexible printed board player, has been despatched.  The Scheme Meeting will be held on the 22nd June. 
  • The Offer Price is HK$1.82/share. It will not be increased. No further dividends will be added, 
  • Trading tight at a gross/annualised spread of 1.1%/6.4%, assuming payment in early August.

CALB Pre-IPO – The Positives – Has Been Growing Fast

By Sumeet Singh

  • CALB aims to raise around US$1.5bn in its Hong Kong IPO.
  • CALB undertakes design, R&D, production and sales of EV batteries and Energy Storage Systems (ESS) products. 
  • In this note, we will talk about the positive aspects of the deal.

Morning Views Asia: Alam Sutera Realty, Country Garden Holdings Co, Fantasia Holdings Group Co

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: Beijing Tongrentang Co A, China Conch Environment Protection Holdings, Huadong Medicine Co Ltd A and more

By | China, Daily Briefs

In today’s briefing:

  • SSE180/​​SSE380 Index Rebalance: Potential MSCI/​FTSE Adds & Deletes
  • Conch Environment (587 HK): Don’t Overly Bet on the Blue Sky Scenario
  • Huadong Medicine Co Ltd (000963.CH) – A “Dark Horse” to Reverse Performance Dilemma

SSE180/​​SSE380 Index Rebalance: Potential MSCI/​FTSE Adds & Deletes

By Brian Freitas

  • There are 18 changes to the SSE180 Index and 38 changes to the SSE380 Index that will be implemented at the close of trading on 9 June.
  • There will be 9 deletions from the MSCI Standard Index and 22 deletions from the FTSE All-World/All-Cap indices at the close on 9 June.
  • Currently, 16 stocks meet the threshold/are close for inclusion in the MSCI China Index while there are 38 stocks that meet the threshold for inclusion in the FTSE All-World/All-Cap indices.

Conch Environment (587 HK): Don’t Overly Bet on the Blue Sky Scenario

By Osbert Tang, CFA

  • The sharp plunge in share price of China Conch Environment Protection Holdings (587 HK) has not yet brought its valuations back to more reasonable levels and we see more downside.
  • Its 10.1x PER for FY22F is at a significant premium over peer average. Even taking into account the impressive ROE, we still cannot find justifications for its high P/B multiple.  
  • Negative catalysts include overly aggressive expansion target, slower profit growth than rise in capacity and surge in gearing and finance costs – they will potentially lead to earnings disappointment.

Huadong Medicine Co Ltd (000963.CH) – A “Dark Horse” to Reverse Performance Dilemma

By Xinyao (Criss) Wang

  • The most recent two quarters have maintained positive growth. It is of great significance for Huadong, who once suffered a significant decline and now in a critical period of transformation.
  • The large growth potential of medical cosmetology and industrial microbiology would be important driver for future development. It’s also wise to strike a balance between current performance and future strategy.
  • Huadong’s revenue growth would be above 10% in next few years. It would have higher valuation than Imeik. Investors are advised to follow Huadong. It could be a “dark horse”.

Before it’s here, it’s on Smartkarma

China: Jinko Solar, Shanghai Pudong Development Bank Co., TBEA Co Ltd A, Apple Inc, Dongzheng Automotive Finance and more

By | China, Daily Briefs

In today’s briefing:

  • STAR50 Index Rebalance: Dear Index Committee…
  • SSE50 Index Rebalance: Some Large Impact Changes
  • CSI300 Index Rebalance: Big Sector Shift with 28 Changes
  • Harding Loevner Global Equity Fund Q1 2022 Letter
  • Dongzheng’s Potential MGO Price from SAIC at HK$1.2430

STAR50 Index Rebalance: Dear Index Committee…

By Brian Freitas

  • The index committee has continued to use a 6 month minimum listing history leading to five changes to the SSE STAR50 (STAR50 INDEX) in June.
  • One way turnover is estimated at 8.56% and will result in a one-way trade of CNY 3,496m. Passive trackers will need to trade between 2-6 days ADV on the adds/deletes.
  • The inclusions have outperformed the deletions and the CSI500 Index since the end of the review period with all inclusions moving higher over the period.

SSE50 Index Rebalance: Some Large Impact Changes

By Brian Freitas

  • There are 5 changes for the SSE50 Index that will be implemented at the close on 9 June. The impact is pretty chunky on a few deletions.
  • Apart from the passive assets tracking the index, there are some liquid index futures and the impact on the stocks will be larger than just the headline numbers.
  • The adds underperformed the deletes in March and April but have come roaring back in May. Playing the trade via long/short pairs could provide better risk adjusted returns.

CSI300 Index Rebalance: Big Sector Shift with 28 Changes

By Brian Freitas

  • There are 28 changes for the Shanghai Shenzhen CSI 300 Index (SHSZ300 INDEX) at the upcoming rebalance that will be implemented at the close of trading on 9 June.
  • We had forecast nearly all the changes, though the index committee seems to have used discretion in deciding not to add three Distillers to the index, leading to other changes.
  • There’s a large sector skew with Industrials, Information Technology and Materials stocks taking 17 more spots in the index, while Health Care and Financials lose 9 and 5 spots respectively.

Harding Loevner Global Equity Fund Q1 2022 Letter

By Fund Newsletters

  • Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989.
  • Stock markets fell in the quarter, as the world watched in horror Russia’s invasion of Ukraine.
  • China-based WuXi Biologics illustrates the perfect storm of macro issues pressuring the share prices of our rapidly growing companies.
  • As questions mount whether globalization has reached a tipping point, companies are taking full advantage of the many advances occurring across the industrial automation landscape— propelling leadingp roviders of “Industry 4.0” solutions onto favorable growth paths.

Dongzheng’s Potential MGO Price from SAIC at HK$1.2430

By Arun George

  • The potential MGO price is HK$1.2430 per H Share vs Dongzheng Automotive Finance (2718 HK)’s previously noted HK$1.294 per H Share due to the change in RMB/HK$ rates.
  • The completion procedures for the auction will take place within six months. Approvals have low risk as the SAIC Motor (600104 CH)’s controlling shareholder is owned by the Shanghai SASAC.
  • At the last close and for a 1 November completion, the gross and annualised spread to the MGO price is 5.3% and 12.7%, respectively.

Before it’s here, it’s on Smartkarma

China: Dongzheng Automotive Finance, CanSino Biologics Inc, Kweichow Moutai, Beijing Enterprises Urban Resources, Beauty Farm Medical and Health Industry, AIA Group Ltd, Lenovo, Agile Property Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • SAIC’s Unconditional Offer For Dongzheng
  • Shanghai/​Shenzhen Southbound Connect: Weekly Moves (27 May 2022)
  • Shanghai/​Shenzhen Northbound Connect: Weekly Moves (27 May 2022)
  • Beijing Enterprises Urban Resources’ MGO Open, First Closing Date 17 June
  • Beauty Farm Medical and Health Industry Pre-IPO: Near-Term Operating Environment Is Not Beautiful
  • Harding Loevner Emerging Markets Equity Fund Q1 2022 Letter
  • Harding Loevner Emerging Markets Equity Fund Q1 2022 Letter
  • Weekly Wrap – 27 May 2022
  • Chinese Property Weekly – 27 May 2022 – Lucror Analytics
  • Chinese Property Weekly – 27 May 2022 – Lucror Analytics

SAIC’s Unconditional Offer For Dongzheng

By David Blennerhassett


Shanghai/​Shenzhen Southbound Connect: Weekly Moves (27 May 2022)

By David Blennerhassett

  • Inside is a recap of movements in the last week relating to the Shanghai and Shenzhen-Hong Kong Stock Connect facilities, broken down by company and industry. 
  • Overall, net inflow was ~US$1.1bn, split evenly (roughly) between Shanghai and Shenzhen. 
  • The largest inflows were into  China Mobile (941 HK) and CNOOC Ltd (883 HK). The largest outflows were in Kuaishou Technology (1024 HK) and BYD (1211 HK).

Shanghai/​Shenzhen Northbound Connect: Weekly Moves (27 May 2022)

By David Blennerhassett


Beijing Enterprises Urban Resources’ MGO Open, First Closing Date 17 June

By Arun George

  • Beijing Enterprises Urban Resources (3718 HK) composite document is out with the MGO’s first closing date of 17 June. The IFA considers Beijing Enterprises Water Group (371 HK)‘s offer fair. 
  • The MGO is conditional on the offeror and concert parties holding more than 50% of the voting rights. With the offeror currently at 44.16%, the MGO should become unconditional. 
  • At last close and for a 28 June payment, the gross and annualised spread to the MGO price (including final dividend) of HK$0.81 per share is 2.5% and 31.5%, respectively.

Beauty Farm Medical and Health Industry Pre-IPO: Near-Term Operating Environment Is Not Beautiful

By Tina Banerjee

  • Beauty Farm Medical and Health Industry (BFM HK), second largest body and skin care service provider in China has filed for IPO on the Hong Kong Stock Exchange.  
  • Large and growing addressable market, comprehensive service offering, nationwide store network, and sound financial position are the major strengths of the company.
  • BFM’s operation faces uncertainties over COVID and related restrictions. This IPO is not expected to see listing gain unless general market condition and China’s economic growth outlook improve.

Harding Loevner Emerging Markets Equity Fund Q1 2022 Letter

By Fund Newsletters

  • Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989.
  • Emerging Markets (EMs) declined sharply, primarily due to the collapse in Russian equities brought about by economic sanctions against Russia because of its invasion of Ukraine, as well as poor performance in China.
  • The EM landscape is currently fogged by an exceptional confluence of risks: armed conflict in Ukraine, inflation, rising interest rates, volatile commodity prices, and concerns about food and energy security.
  • Although we made only a handful of transactions this quarter, the portfolio’s profile changed significantly because of the write-down of our Russian holdings and the outsized returns of stocks benefiting from commodity price inflation.

Harding Loevner Emerging Markets Equity Fund Q1 2022 Letter

By Fund Newsletters

  • Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989.
  • Emerging Markets (EMs) declined sharply, primarily due to the collapse in Russian equities brought about by economic sanctions against Russia because of its invasion of Ukraine, as well as poor performance in China.
  • The EM landscape is currently fogged by an exceptional confluence of risks: armed conflict in Ukraine, inflation, rising interest rates, volatile commodity prices, and concerns about food and energy security.
  • Although we made only a handful of transactions this quarter, the portfolio’s profile changed significantly because of the write-down of our Russian holdings and the outsized returns of stocks benefiting from commodity price inflation.

Weekly Wrap – 27 May 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Adani Ports & Special Economic Zone
  2. Yanzhou Coal Mining Company Limited H
  3. Vedanta Resources
  4. Indika Energy
  5. Pakuwon Jati

and more…


Chinese Property Weekly – 27 May 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Chinese Property Weekly – 27 May 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Before it’s here, it’s on Smartkarma